Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance

@inproceedings{Willits2017SpectraOF,
  title={Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance},
  author={Iain Willits and Helen Cole and Roseanne Jones and Kimberley Carter and Mick Arber and Michelle Jenks and Joyce A. Craig and Andrew J. Sims},
  booktitle={Applied health economics and health policy},
  year={2017}
}
The Spectra Optia® automated apheresis system, indicated for red blood cell exchange in people with sickle cell disease, underwent evaluation by the National Institute for Health and Care Excellence, which uses its Medical Technologies Advisory Committee to make recommendations. The company (Terumo Medical Corporation) produced a submission making a case… CONTINUE READING